PMD Key Statistics, Chart & Performance
The current stock price of PMD is 2.67 USD. In the past month the price increased by 13.86%. In the past year, price decreased by -10.4%.
PMD Latest News, Press Relases and Analysis
PMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.17 | 97.15B | ||
| CI | THE CIGNA GROUP | 9.28 | 70.40B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 118.23 | 21.75B | ||
| LH | LABCORP HOLDINGS INC | 16.43 | 21.55B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.63 | 20.23B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.42B | ||
| HIMS | HIMS & HERS HEALTH INC | 72.44 | 8.91B | ||
| DVA | DAVITA INC | 12.68 | 8.26B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 33.86 | 6.23B | ||
| RDNT | RADNET INC | 200.42 | 5.88B | ||
| CHE | CHEMED CORP | 18.75 | 5.84B | ||
| OPCH | OPTION CARE HEALTH INC | 20.53 | 4.86B |
Related stock screener links
About PMD
Company Profile
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 116 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. The company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The firm markets its corporate drug testing services through its own sales force, distributors, and partners. The company markets its home drug testing service, PDT-90, through the Internet.
Company Info
PSYCHEMEDICS CORP
125 Nagog Park
Acton MASSACHUSETTS 01720 US
CEO: Raymond C. Kubacki
Employees: 116
Phone: 19782068220
PSYCHEMEDICS CORP / PMD FAQ
What does PMD do?
Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 116 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. The company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The firm markets its corporate drug testing services through its own sales force, distributors, and partners. The company markets its home drug testing service, PDT-90, through the Internet.
What is the current price of PMD stock?
The current stock price of PMD is 2.67 USD. The price decreased by -1.84% in the last trading session.
Does PSYCHEMEDICS CORP pay dividends?
PSYCHEMEDICS CORP (PMD) has a dividend yield of 12.67%. The yearly dividend amount is currently 0.14.
What is the ChartMill rating of PSYCHEMEDICS CORP stock?
PMD has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the GICS sector and industry of PMD stock?
PSYCHEMEDICS CORP (PMD) operates in the Health Care sector and the Health Care Providers & Services industry.
Can you provide the ownership details for PMD stock?
You can find the ownership structure of PSYCHEMEDICS CORP (PMD) on the Ownership tab.
PMD Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to PMD. When comparing the yearly performance of all stocks, PMD turns out to be only a medium performer in the overall market: it outperformed 54.69% of all stocks.
PMD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PMD. PMD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
PMD Financial Highlights
Over the last trailing twelve months PMD reported a non-GAAP Earnings per Share(EPS) of -0.51. The EPS increased by 24.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -30.45% | ||
| ROE | -54.99% | ||
| Debt/Equity | 0.09 |